Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

BACKGROUND: The efficacy and safety of nivolumab versus chemotherapy was evaluated in the Japanese subpopulation from the overall intent-to-treat (ITT) population of the ATTRACTION-3 trial conducted in patients with advanced esophageal squamous cell carcinoma (ESCC) as second-line treatment. METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Esophagus
Main Authors: Takahashi, Masanobu, Kato, Ken, Okada, Morihito, Chin, Keisho, Kadowaki, Shigenori, Hamamoto, Yasuo, Doki, Yuichiro, Kubota, Yutaro, Kawakami, Hisato, Ogata, Takashi, Hara, Hiroki, Muto, Manabu, Nakashima, Yuichiro, Ishihara, Ryu, Tsuda, Masahiro, Motoyama, Satoru, Kodani, Mamoru, Kitagawa, Yuko
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Singapore 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794205/
https://ncbi.nlm.nih.gov/pubmed/33170461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10388-020-00794-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados